Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.

@article{Wu2010SafetyAE,
  title={Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.},
  author={Jiang Wu and Fujie Xu and L. Lu and Min Lu and L. Miao and Ting Gao and W. Ji and L. Suo and D. Liu and R. Ma and Rui Yu and Jiazi Zhangzhu and Weixiang Liu and Yang Zeng and Xiaomei Li and Xuechun Zhang and X. Pang and Ying Deng},
  journal={The New England journal of medicine},
  year={2010},
  volume={363 25},
  pages={
          2416-23
        }
}
BACKGROUND After the first monovalent 2009 pandemic influenza A (H1N1) vaccine became available in September 2009, Chinese officials conducted a mass vaccination program in Beijing. We evaluated the safety and effectiveness of the vaccine. METHODS During a 5-day period in September 2009, a total of 95,244 children and adults received the PANFLU.1 vaccine (Sinovac Biotech), a monovalent split-virion vaccine of 15 μg of hemagglutinin antigen without adjuvant. We assessed adverse events after… Expand
Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.
Influenza virus vaccines: lessons from the 2009 H1N1 pandemic.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
[A survey on serological epidemiology of influenza A (H1N1) 2009 in Beijing].
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
Epidemiological investigation of an outbreak of pandemic influenza A (H1N1) 2009 in a boarding school: serological analysis of 1570 cases.
  • Tiegang Li, Y. Liu, +15 authors Bojian Zheng
  • Medicine
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
  • 2011
Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
...
1
2
3
...